Neuraltus Pharmaceuticals announced the confirmatory Phase 2 study of the Company’s lead investigational treatment NP001 for amyotrophic lateral sclerosis (ALS,...
Jazz Pharm announced that the first patient has been enrolled in a Phase 2 clinical study evaluating JZP-110 , a...
Takeda Pharma and the Koch Institute for Integrative Cancer Research at MIT jointly announced that Takeda will support groundbreaking science...
Allergan plc , a global leader in eye care for nearly 70 years, announces a bold commitment to fight preventable...
Arven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility...
Zimmer Biomet Holdings Inc , a global leader in musculoskeletal healthcare announced that the U.S. FDA approved an expanded 26-week...
Allergan plc , a leading global biopharmaceutical company announced that it has successfully completed the acquisition of LifeCell Corporation, a...
On February 8th, the EDQM will hold a dedicated session jointly organised with the European Medicines Agency on the role...
NeuroVive Pharmaceutical AB , a company in mitochondrial medicine announced that research resources and activities of the Taiwan-based subsidiary redirected...
Jitsubo Co., Ltd. announced that it has executed the joint development and license agreement with a Japanese pharmaceutical company (undisclosed)...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
